MEDPACE HLDGS INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 829,460 | $252,728,167 | 1.41% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 15, 2025 |
| June 30, 2025 | 945,814 | $296,853,182 | 1.55% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 14, 2025 |
| Sept. 30, 2025 | 925,963 | $476,093,136 | 2.56% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 14, 2025 |
| Dec. 31, 2025 | 648,306 | $364,121,065 | 2.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 12, 2026 |
| March 31, 2026 | 773,931 | $371,633,927 | 2.47% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 21, 2026 |
| June 30, 2026 | 636,595 | $337,134,346 | 2.21% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 10, 2026 |
| Sept. 30, 2026 | 465,944 | $290,832,926 | 2.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 13, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.